The Perceived Influence of Neurofibromatosis Type 1(NF1) on the Parents' Relationship

被引:0
|
作者
Wiener, Lori [1 ]
Bedoya, Sima Zadeh [1 ]
Goyal, Archita [1 ,2 ]
Gordon, Mallorie [1 ]
Deuitch, Natalie [3 ]
Widemann, Brigitte [1 ]
机构
[1] NIH, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[2] Tufts Univ, Sch Med, Boston, MA 02111 USA
[3] NIH, Translat & Funct Genom Branch, Natl Human Genome Res, Bethesda, MD 20892 USA
来源
CHILDREN-BASEL | 2023年 / 10卷 / 03期
基金
美国国家卫生研究院;
关键词
Neurofibromatosis type I (NF1); parents; couples; dyadic coping; marriage; partnership; counseling; DYADIC ADJUSTMENT; CHILDREN; QUALITY; COUPLES; CANCER; CHILDHOOD; DIAGNOSIS; YOUTH;
D O I
10.3390/children10030448
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Neurofibromatosis type 1 (NF1) is a genetic condition affecting 1 in 3000 individuals. Having a child with a chronic illness can introduce both practical and emotional challenges to a parental relationship. This cross-sectional study was administered to 50 parents of children with NF1, diagnosed between the ages of 1-24. Each participant was provided a 50-item self-report survey to complete during an inpatient or outpatient visit. The survey gathered information on the participants' views of the spouse/partner relationship, coping mechanisms, and elements that supported emotional connections. While the majority of parental relationships were reported to remain strong, the mean relationship quality was perceived to have decreased compared to prior to the child's diagnosis. Compassionate and open communication, shared perspective, having time alone with their partner outside of medical situations, and dyadic coping were identified as strategies that could strengthen the relationship. The identified stressors to the parental relationship during the NF1 illness trajectory can inform interventions and help guide development of a couple's intervention. The National Cancer Institute, NIH Institutional Review Board approved this study (12-C-0206).
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Trabecular Bone Score (TBS) and Bone Metabolism in Patients Affected with Type 1 Neurofibromatosis (NF1)
    Filopanti, Marcello
    Verga, Uberta
    Ulivieri, Fabio Massimo
    Giavoli, Claudia
    Rodari, Giulia
    Arosio, Maura
    Natacci, Federica
    Spada, Anna
    CALCIFIED TISSUE INTERNATIONAL, 2019, 104 (02) : 207 - 213
  • [42] Mutation analysis and clinical profile of South African patients with Neurofibromatosis type 1 (NF1) phenotype
    Mudau, Maria Mabyalwa
    Dillon, Bronwyn
    Smal, Clarice
    Feben, Candice
    Honey, Engela
    Carstens, Nadia
    Krause, Amanda
    FRONTIERS IN GENETICS, 2024, 15
  • [43] INTERVENTIONS FOR COGNITIVE IMPAIRMENT IN CHILDREN WITH NEUROFIBROMATOSIS TYPE 1 (NF1): WHAT WORKS AND FUTURE DIRECTIONS
    Barton, B.
    JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2017, 61 (09) : 825 - 825
  • [44] Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study
    Yang, Xiaoqin
    Yoo, Hyun Kyoo
    Amin, Suvina
    Cheng, Wendy Y.
    Sundaresan, Sanjana
    Zhang, Lujia
    Duh, Mei S.
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1221 - 1233
  • [45] Cohort profile: life with neurofibromatosis 1-the Danish NF1 cohort
    Doser, Karoline
    Hove, Hanne
    Ostergaard, John R.
    Bidstrup, Pernille E.
    Dalton, Susanne O.
    Handrup, Mette Moller
    Ejerskov, Cecilie
    Kroyer, Anja
    Doherty, Mia Aagaard
    Jepsen, Jens Richardt Mollegaard
    Mulvihill, John J.
    Winther, Jeanette F.
    Kenborg, Line
    BMJ OPEN, 2022, 12 (09):
  • [46] Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
    Baudou, Eloise
    Nemmi, Federico
    Biotteau, Maelle
    Maziero, Stephanie
    Assaiante, Christine
    Cignetti, Fabien
    Vaugoyeau, Marianne
    Audic, Frederique
    Peran, Patrice
    Chaix, Yves
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2020, 28 : 89 - 100
  • [47] A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
    Curlee, Millicent S.
    Toledo-Tamula, Mary Anne
    Baker, Melissa
    Wikstrom, Daniel
    Harrison, Cynthia
    Rhodes, Amanda
    Fagan, Margaret
    Tibery, Cecilia
    Wolters, Pamela L.
    Widemann, Brigitte C.
    Gross, Andrea M.
    Martin, Staci
    CANCERS, 2025, 17 (02)
  • [48] Biallelic NF1 inactivation in high grade serous ovarian cancers from patients with neurofibromatosis type 1
    Eliza Courtney
    Sock Hoai Chan
    Shao Tzu Li
    Diana Ishak
    Khurshid Merchant
    Tarryn Shaw
    Wen Yee Chay
    Felicia Hui Xian Chin
    Wai Loong Wong
    Adele Wong
    Joanne Ngeow
    Familial Cancer, 2020, 19 : 353 - 358
  • [49] Conflict processing in juvenile patients with neurofibromatosis type 1 (NF1) and healthy controls - Two pathways to success
    Bluschke, Annet
    von der Hagen, Maja
    Papenhagen, Katharina
    Roessner, Veit
    Beste, Christian
    NEUROIMAGE-CLINICAL, 2017, 14 : 499 - 505
  • [50] Differential MSH2 promoter methylation in blood cells of Neurofibromatosis type 1 (NF1) patients
    Titze, Sabrina
    Peters, Hartmut
    Waehrisch, Sandra
    Harder, Thomas
    Guse, Katrin
    Buske, Annegret
    Tinschert, Sigrid
    Harder, Anja
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2010, 18 (01) : 81 - 87